OVATION 3 is IMUNON’s pivotal Phase 3 study of IMMN-001, an IL-12 gene-mediated immunotherapy, in women with advanced stage epithelial ovarian cancer. The study is supported with unprecedented overall ...

What I saw, as federal agents stormed the city and residents banded together to protect themselves, was a dark, dystopian ...

SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today announced ...

Beyond Azerbaijan and Armenia in the Trans-Caspian region, Georgia stands out as a nation that not only shares core Western civilizational values (faith, free expression, and national sovereignty) but ...

The efficacy of adeno-associated virus (AAV)-mediated gene therapy for the inner ear is fundamentally constrained by the natural tropism of viral ...

After years of faltering talks, the EU and India have struck a landmark free trade deal that goes far beyond tariffs. In an ...

"We are delighted that the clinical development of these promising therapeutics will continue at NeoTrail with an opportunity ...

The market is poised for growth (12.88% CAGR), driven by high demand for equipment due to capacity expansions, and the adoption of single-use systems, continuous bioprocessing, and digital twinsDublin ...

Glycolic acid has become a darling of contemporary skincare due to its power to change dull and uneven skin into a brighter, smoother version. From fading pigmentation to unclogging pores and ...

Dear Annie: My name is Rosalynn. Growing up, my family called me Rosie. I never minded it, but once I left home, I started going by Rosa, which I felt seemed better suited to the working world and ...

According to recent scientific literature, at low doses, castanospermine modulates carbohydrate metabolism, altering glycogen, glucose levels, and other clinical markers. In animal models, high doses ...

Regenxbio Inc. faces pivotal catalysts in 2026, notably RGX-121's FDA decision and RGX-202 Duchenne data, potentially ...